You just read:

Malaria Vaccine Developer Sanaria Inc. and the Institute for Bioscience and Biotechnology Research of the University of Maryland College Park Awarded Collaborative, US $3M NIH Phase II Small Business Innovation Research Grant

News provided by

Sanaria Inc.

13 Jun, 2012, 23:06 BST